Hobart Private Capital’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-181,847
| Closed | -$9.56M | – | 46 |
|
|
2022
Q4 | $9.56M | Buy |
181,847
+1,518
| +0.8% | +$79.8K | 6.47% | 3 |
|
|
2022
Q3 | $8.51M | Buy |
180,329
+195
| +0.1% | +$9.2K | 6.11% | 5 |
|
|
2022
Q2 | $9.09M | Buy |
180,134
+17,027
| +10% | +$859K | 4.25% | 7 |
|
|
2022
Q1 | $9.94M | Buy |
163,107
+38,063
| +30% | +$2.32M | 3.83% | 8 |
|
|
2021
Q4 | $8.23M | Buy |
+125,044
| New | +$8.23M | 3.09% | 11 |
|
|
2021
Q3 | – | Sell |
-44,358
| Closed | -$2.67M | – | 111 |
|
|
2021
Q2 | $2.67M | Sell |
44,358
-3,762
| -8% | -$226K | 1.1% | 16 |
|
|
2021
Q1 | $2.65M | Sell |
48,120
-25,224
| -34% | -$1.39M | 1.08% | 18 |
|
|
2020
Q4 | $4M | Buy |
73,344
+4,002
| +6% | +$218K | 1.75% | 12 |
|
|
2020
Q3 | $3.46M | Buy |
69,342
+11,838
| +21% | +$591K | 1.79% | 14 |
|
|
2020
Q2 | $2.54M | Buy |
+57,504
| New | +$2.54M | 1.43% | 17 |
|